Respuesta clínica y neurofisiológica a la efedrina en un paciente con síndrome miasténico congénito de canal lento

Eirís-Puñal, Jesús; Fuentes-Pita, Patricia; Gómez-Lado, Carmen; Pérez-Gay, Laura; López-Vázquez, Ana; Quintas-Rey, Rita; Barros-Angueira, Francisco; Pardo, Julio.
Rev. neurol. (Ed. impr.) ; 71(6): 221-224, 16 sept., 2020. graf
Artículo en Español | IBECS (España) | ID: ibc-195515

Documentos relacionados

  1. VAMP1-Related Congenital Myasthenic Syndrome: A Case Report and Literature Review.
  2. Pregnancy outcomes in patients with congenital myasthenic syndromes.
  3. New insights on the disease contribution of neuroinflammation in amyotrophic lateral sclerosis.
  4. Congenital myasthenic syndrome by mutation of the ColQ gene: Phenotypic and evolutionary profile of three Algerian families.
  5. Genetic analysis of a family affected by congenital myasthenic syndrome due to a Novel mutation in the SLC5A7 gene.
  6. [Prenatal diagnosis of a case with Congenital myasthenic syndrome due to compound heterozygous variants of SCN4A gene].
  7. Expanding the spectrum of LAMB2: Pierson syndrome associated with neuromuscular junction disorder in two patients.
  8. COLQ-related congenital myasthenic syndrome: An integrative view.
  9. Clinicopathological-genetic features of congenital myasthenic syndrome from a Chinese neuromuscular centre.
  10. Congenital myasthenic syndrome: Correlation between clinical features and molecular diagnosis.